Case Study

KD Pharma Group

New Commitment

The company

Region: Europe
Sector: Healthcare
Highlights:

                                £7.5m
Commitment

                                500
Full time employees, six sites, seven countries

Private Equity Manager (GP)

Case study

About the company

KD Pharma Group is a leading global producer of Omega-3 ingredients focused on highly purified Omega-3 fatty acids for pharmaceutical and nutraceutical products.

Investment rationale

KD Pharma Group is a market-leading business with key competitive advantages based on patented technology and processes. The company has an integrated supply chain that facilitates margin benefits, a strong repeat client base, and a strong brand based upon being a reliable and consistent producer of high-quality Active Pharmaceutical Ingredients (APIs).

KD Pharma has grown from a single-digit revenue business to one of the industry’s largest players.

Our relationship

PIP’s long-standing relationship with German mid-market buyout firm capiton, which started with a series of primary investments, has enabled PIP to participate in this attractive investment opportunity.

Back to case studies

You may also like

Our portfolio

Actively managed for our shareholders

PIP's global, diversified portfolio gives exposure to many high quality managers, sectors and companies.

Find out more

Our investment process

Decades of experience, expertise and deep relationships

We have a rigorous and detailed approach to selecting our private equity managers and assessing deals.

Find out more

The information contained on this website is communicated by Pantheon Ventures (UK) LLP, a limited liability partnership incorporated in England and Wales, authorised and regulated by the Financial Conduct Authority in the United Kingdom under laws that differ from Australian laws. The Company does not hold an Australian financial services license that authorises it to provide advice in relation to the acquisition of securities in the Company. Pantheon Ventures (UK) LLP is exempt from the requirement to hold an Australian financial services licence under the Corporations Act 2001 (“Corporations Act”) in respect of the provision of financial services to wholesale clients in Australia. Pantheon Ventures (UK) LLP relies on the Corporations (Repeal and Transitional) Instrument 2016/396, which grants transitional continuance relief to foreign financial services providers relying on Australian Securities and Investments Commission Class Order 03/1099 in order to provide financial services to wholesale clients in Australia. This website and the information contained on it is intended only for persons in Australia who are both wholesale clients under section 761G of the Corporations Act 2001 (Cth) and professional investors or sophisticated investors for the purposes of section 708 of the Corporations Act.

Before acting on the information contained on this website, you should consider the appropriateness of the information and obtain specific advice from a professional adviser. No cooling-off regime applies to an acquisition of securities in the Company.

Any information provided in respect of the Company is not a prospectus, product disclosure statement or any other form of disclosure document for the purposes of Chapter 6D or Part 7.9 of the Corporations Act and does not purport to include the information required of a prospectus, product disclosure statement or any other form of disclosure document required under the Corporations Act.

I am both a wholesale client under section 761G of the Corporations Act 2001 (Cth) and a professional investor or sophisticated investor for the purposes of section 708 of the Corporations Act:

By clicking on the “Agree” button below, you confirm, represent and warrant to the Company and to the Investment Manager that you are a person in Australia who is both a wholesale client under section 761G of the Corporations Act 2001 (Cth) and a professional investor or sophisticated investor for the purposes of section 708 of the Corporations Act and you agree that you will not forward, distribute or send any materials contained in this website to any person other than persons who are both wholesale clients and professional investors or sophisticated investors in Australia.

I have read and understood the terms set out above and in the Company’s legal and risk notice, which I understand may affect my rights and I agree to be bound by those terms. By clicking on the “Agree” button below, I confirm that I am permitted to access the website.